This is a material commercial barrier in practice because physicians tend not to actively switch stable patients from a working biologic to a biosimilar unless they or their health system has a strong incentive to do so
In the obesity trial of 48 week-duration, percentage change in body weight from baseline after 24 weeks and 48 weeks were the primary and secondary outcomes respectively
These products are not drugs, foods, cosmetics, diagnostic products, or dietary supplements, have not been evaluated by the FDA, and are not intended for human or animal use
Erbin is connected to various clinical diseases
ICT manages and operates the Texas Fusion Center, formerly called the Texas Joint Crime Information Center (TXJCIC), which serves as the centerpiece in establishing and maintaining a statewide information sharing network
GLP-1 reduces glucagon secretion from the pancreas